Cargando…

Systemic Sclerosis Associated Interstitial Lung Disease and Nintedanib: A Rare Disease and a Promising Drug

Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a rare disease with a progressive nature, eventually leading to lung fibrosis. Nintedanib, a tyrosine kinase inhibitor, is a widely accepted drug for treating idiopathic pulmonary fibrosis (IPF), a disease that shares some similari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kafle, Sunam, Thapa Magar, Manusha, Patel, Priyanka, Poudel, Arisa, Cancarevic, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364831/ https://www.ncbi.nlm.nih.gov/pubmed/34414042 http://dx.doi.org/10.7759/cureus.16404

Ejemplares similares

Influence of Microbiome and Antibiotics on the Efficacy of Immune Checkpoint Inhibitors
por: Patel, Priyanka, et al.
Publicado: (2021)

Takayasu's Arteritis and Its Association With Mycobacterium Tuberculosis: A Systematic Review
por: Thapa Magar, Manusha, et al.
Publicado: (2021)

Association of Vitamin D Deficiency With Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis
por: Kafle, Sunam, et al.
Publicado: (2021)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

Significance of Homocysteine Levels in the Management of Polycystic Ovarian Syndrome: A Literature Review
por: Kondapaneni, Varshitha, et al.
Publicado: (2020)

Role of Inhalational Aztreonam Lysine in Lower Airway Infections in Cystic Fibrosis: An Updated Literature Review
por: Zeb, Mehwish, et al.
Publicado: (2022)

Role of Substance P in the Pathophysiology of Inflammatory Bowel Disease and Its Correlation With the Degree of Inflammation
por: Patel, Mauli, et al.
Publicado: (2020)

Biologics Targeting in the Treatment of Inflammatory Bowel Disease: A Conundrum
por: Rehman, Mahnoor, et al.
Publicado: (2020)

Is Estrogen a Curse or a Blessing in Disguise? Role of Estrogen in Gastroesophageal Reflux Disease
por: Kang, Ayesha, et al.
Publicado: (2020)

A Case of Progressive Dyspnea: Lymphocytic Interstitial Pneumonia in Collagen Vascular Disease
por: Moore, Jonathan, et al.
Publicado: (2021)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis With Pirfenidone and Nintedanib: A Friend or Foe
por: Kaushal, Mohit, et al.
Publicado: (2022)

Role of Hydrogen Sulfide in the Treatment of Fibrosis
por: Chirindoth, Swathy S, et al.
Publicado: (2021)

Efficacy and Tolerability of Nintedanib in Idiopathic-Inflammatory-Myopathy-Related Interstitial Lung Disease: A Pilot Study
por: Liang, Junyu, et al.
Publicado: (2021)

Radiation-Induced Lung Injury With Lung Cancer Treated With the Combination Therapy of Nintedanib and Dexamethasone
por: Itano, Junko, et al.
Publicado: (2023)

Survival of the Fittest: Addressing the Disparities in the Burden of Chronic Kidney Disease
por: Nelson, Maxine L, et al.
Publicado: (2020)

Use of Rituximab in Management of Rapidly Progressive Glomerulonephritis
por: Cancarevic, Ivan, et al.
Publicado: (2020)

Hypophosphatemia in Patients With Multiple Myeloma
por: Cancarevic, Ivan, et al.
Publicado: (2023)

Effectiveness and Safety of Pirfenidone and Nintedanib for Pulmonary Fibrosis in COVID-19-Induced Severe Pneumonia: An Interventional Study
por: Choudhary, Rajkamal, et al.
Publicado: (2022)

Metformin-Induced Eosinophilic Interstitial Lung Disease
por: Alyami, Sami M, et al.
Publicado: (2023)

Recent Advances in the Treatment of Interstitial Lung Diseases
por: Bang, Aneesh A, et al.
Publicado: (2023)

Uncommon Presentations of Multiple Myeloma
por: Tathineni, Praveena, et al.
Publicado: (2020)

Clozapine-Related Thromboembolic Events
por: Pallares Vela, Elisa, et al.
Publicado: (2021)

Is Prophylaxis the Only Way Out for Cytokine Release Syndrome Associated With Chimeric Antigen T-cell Therapy?
por: Dave, Prashil, et al.
Publicado: (2021)

A Rare Case of Irinotecan-induced Interstitial Pulmonary Disease and Diffuse Alveolar Hemorrhage in a Patient with Pancreatic Cancer
por: Meng, Lingbin, et al.
Publicado: (2019)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Nintedanib in children and adolescents with fibrosing interstitial lung diseases
por: Deterding, Robin, et al.
Publicado: (2023)

Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis‐associated interstitial lung disease
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

A Man With Recurrent Pneumonitis: A Rare Case of Interstitial Lung Disease Associated With Anti-Mi-2 Beta-Specific Dermatomyositis
por: Ahmad, Anam, et al.
Publicado: (2021)

Aortic Involvement in Antineutrophil Cytoplasmic Antibodies Vasculitis, a Coincidence or a Real Association?
por: Tariq, Ezza, et al.
Publicado: (2020)

Ventriculoperitoneal Shunt Migration Inside the Gastric Lumen: A Rare Case Report
por: Sidhu, Jasdeep S, et al.
Publicado: (2019)

Is There a Correlation Between Irritable Bowel Syndrome and Lactose Intolerance?
por: Cancarevic, Ivan, et al.
Publicado: (2020)

Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON
por: Allanore, Yannick, et al.
Publicado: (2022)

Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
por: Khanna, Dinesh, et al.
Publicado: (2023)

Efficacy and Safety of Nintedanib in Patients with Interstitial Lung Disease with or without Systemic Sclerosis: A Meta-Analysis
por: Lee, Young Ho, et al.
Publicado: (2023)

Role of High-Resolution CT Thorax in Diagnosing Interstitial Lung Disease and Its Association With Smoking and Connective Tissue Disorder
por: Doshi, Jainam A, et al.
Publicado: (2022)

Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases
por: Ito, Yoko, et al.
Publicado: (2019)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Effects of nintedanib by inclusion criteria for progression of interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_alo184jvaik2vmdtuc15bkh9ot